AbCellera Signs a Research Agreement with Bill & Melinda Gates Foundation to Accelerate Global Health Research
Shots:
- Bill & Melinda Gates Foundation provides $4.8M fund to AbCellera to develop Ab for infectious diseases including HIV- malaria & tuberculosis
- The focus of the agreement is to get benefit from AbCellera’s Ab discovery technology and development of vaccines with the improvement in QoL
- AbCellera’s single-cell screening technology is a combination of live-cell assays to develop therapies for targets such as membrane proteins- GPCRs and ion channels in multiple therapy areas. In 2017- AbCellera collaborated with Gates Foundation to discover mAb against 10 biomarkers associated with tuberculosis
Ref: AbCellera | Image: Twitter
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com